Leptin-based immune intervention: Current status and future directions

Current Opinion in Investigational Drugs

Volumn 4, Issue 11, 2003, Pages 1327-1332

  La Cava, Antonio ^a   Matarese, Giuseppe ^b   Ebling, Fanny M ^a   Hahn, Bevra H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Autoimmunity; Cytokines; Hormones; Immunotherapy; Leptin; T helper 1

Indexed keywords

ANTIBODY; CYTOKINE ANTIBODY; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; JANUS KINASE 2; LEPTIN; LEPTIN ANTAGONIST; LEPTIN ANTIBODY; LEPTIN RECEPTOR; PROTEIN INHIBITOR; PROTEIN SH2; RECOMBINANT LEPTIN RECEPTOR; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CALORIC RESTRICTION; CANCER; CHRONIC INFLAMMATION; DISEASE COURSE; DRUG EFFECT; DRUG TARGETING; ENERGY BALANCE; HORMONE INHIBITION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOREGULATION; IMMUNOTHERAPY; INFLAMMATION; MOLECULAR BIOLOGY; NONHUMAN; NUTRITIONAL STATUS; OBESITY; REVIEW; RHEUMATOID ARTHRITIS; RODENT; SIDE EFFECT; STARVATION; TH1 CELL;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; INFLAMMATION; LEPTIN; NUTRITIONAL STATUS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0345832390     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Matarese G, La Cava A, Sanna V, Lord GM, Lechler RI, Fontana S, Zappacosta S: Balancing susceptibility to injection and autoimmunity: A role for leptin? Trends Immunol (2002) 23(4):182-187. This review proposes a model in which hypoleptinemia secondary to nutritional deficiency may protect individuals from autoimmunity while predisposing them to infections.
2. Gurat T: Obesity research. Leptin not impressive in clinical trial. Science (1999) 286(5441):881-882.
3. Lonnqvist F, Arner P, Nordfors L, Schalling M: Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med (1995) 1(9):950-953.
4. La Cava A, Alviggi C, Matarese G: Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med (2003): in press.
5. Sarraf P, Frederich RC, Turner EM, Ma G, Jaskowiak NT, Rivet DJ 3rd, Flier JS, Lowell BB, Fraker DL, Alexander HR: Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia. J Exp Med (1997) 185(1):171-175. This paper demonstrates that hyperleptinemia plays a significant role in the anorexia that accompanies acute inflammation.
6. Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB: Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol (2000) 168(8):4018-4024.
7. Caldefie-Chezet F, Poulin A, Tridon A, Sion B, Vasson MP: Leptin: A potential regulator of polymorphonuclear neutrophil bactericidal action? J Leukocyte Biol (2001) 69(3):414-418.
8. Lord GM, Matarase G, Howard JK, Baker RJ, Bloom SR, Lechler RI: Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394(6696):897-901. This paper shows that the decrease in leptin that is associated with starvation induces immune suppression.
9. Howard JK, Lord GM, Matarese G, Vendetti S, Ghatei MA, Ritter MA, Lechler RI, Bloom SR: Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest (1999) 104(8):1051-1059. In this paper, it is proposed that reduction of leptin levels can be central to the pathogenesis of starvation-induced lymphoid atrophy.
10. Mandel MA, Mahmoud AA: Impairment of cell-mediated immunity in mutation diabetic mice (db/db). J Immunol (1978) 120(4):1375-1377.
11. Fujita Y, Murakami M, Ogawa Y, Masuzaki H, Tanaka M, Ozaki S, Nakao K, Mimori T: Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin Exp Immunol (2002) 128(1):21-26.
12. Flier JS: Lowered leptin slims immune response. Nat Med (1998) 10(10):1124-1125.
13. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS. Role of leptin in the neuroendocrine response to fasting. Nature (1996) 382(6588):250-252. This paper shows that regulation of the neuroendocrine system and reproductive function is a major physiological role of leptin during starvation.
14. Zabeau L, Lavens D, Peelman F, Eyckerman S, Vandekerckove J, Tavernier J: The ins and outs of leptin receptor activation. FEBS Lett (2003) 546(1):45-50.
15. Bjoraek C, Uotani S, da Silva B, Flier JS: Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem (1997) 272(51):32686-32695.
16. Sweeney G: Leptin signalling. Cell Signal (2002) 14(8):655-663. This review analyzes current data on the leptin receptor signaling pathways.
17. Ghilardi N, Skoda RC: The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol Endocrinol (1997) 11(4):393-399.
18. Li C, Friedman JM: Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction. Proc Natl Acad Sci USA (1999) 96(17):9677-9682.
19. Vaisse C, Halaas JL, Horvath CM, Darnell JE Jr, Stoffel M, Friedman JM: Leptin activation of STAT3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Gener (1996) 414(1):95-97.
20. Harris M, Aschkenasi C, Elias CF, Chandrankunnel A, Nillni EA, Bjoorbaek C, Elmquist JK, Flier JS, Hollenberg AN: Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest (2001) 107(1):111-120.
21. Matarese G, Alviggi C, Sanna V, Howard JK, Lord GM, Carraetta C, Fontana S, Lechler RI, Bloom SR, De Placido G: Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab (2000) 85(7):2483-2487.
22. Schols AM, Creutzberg EC, Buurman WA, Campfield LA, Saris WH, Wouters EF: Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 160(4):1220-1226.
23. Barbier M, Cherbut C, Aube AC, Blottiere HM, Galmiche JP: Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut (1998) 43(6):783-790.
24. Gualillo O, Eiras S, Lago F, Dieguez C, Casanueva FF: Elevated serum leptin concentrations induced by experimental acute inflammation. Life Sci (2000) 67(20):2433-2441.
25. Matarese G, Sanna V, Lechler RI, Sarvetnick N, Fontana S, Zappacosta S, La Cava A: Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes (2002) 51(5):1356-1361.
26. Matarese G, Di Giacomo A, Sanna V, Lord GM, Howard JK, Di Tuoro A, Bloom SR, Lechler RI, Zappacosta S, Fontana S: Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol (2001) 166(10):5909-5916. This paper demonstrates the requirement of leptin for the induction and maintenance of an experimentally induced autoimmune disease in mice.
27. Faggioni R, Jones-Carson J, Reed DA, Dinarello CA, Feingold KR, Grunfeld C, Fantuzzi G: Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxocity: Role of tumor necrosis factor-α and IL-18. Proc Natl Acad Sci USA (2000) 97(5):2367-2372.
28. Ozata M, Ozdemir IC, Licinio J: Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab (1998) 84(10):3686-3695.
29. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A et al: A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature (1998) 392(6674):398-401.
30. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S: Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med (1999) 341(12):879-884. This paper represents the first report of the therapeutic use of leptin in a leptin-deficient patient.
31. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S, Lechler RI et al: Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest (2002) 110(8):1093-1103. This paper reports that subcutaneous long-term administration of recombinant human leptin had sustained beneficial effects on multiple physiological, endocrine, metabolic and immune parameters in three genetically leptin-deficient children.
32. Sanna V, Di Giacomo A, La Cava A, Lechler RI, Fontana S, Zappacosta S, Matarese G: Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest (2003) 111(2):241-250. This paper describes the potent effects leptin (which is produced at the site of autoimmune pathology) on Th1 autoimmunity and the beneficial effect of a short fast on the downregulation of an incipient attack of autoimmunity.
33. La Cava A, Sarvetnick N: The role of cytokines in autoimmune diseases. In: Genes and Genetics of Autoimmunity. Current Directions in Autoimmunity. Theofilopoulos AN (Ed), Karger AG, Basel, Switzerland (1999):56-71.
34. La Cava A: Cytokines and autoimmune rheumatic diseases. Int J Adv Rheumatol (2003) 1:10-19.
35. Matzoros CS, Prasad AS, Beck FW, Grabowski S, Kaplan J, Adair C, Brewer GJ: Zinc may regulate serum leptin concentrations in humans. J Am Coll Nutr (1998) 17(3):270-275.
36. Fraser DA, Thoen J, Reseland JE, Forre O, Kjeldsen-Kragh J: Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol (1999) 18(5):394-401.
37. Yang S, Lin HZ, Hwang J, Chacko VP, Diehl AM: Hepatic hyperplasia in noncirrhotic fatty livers: Is obesity-related hepatic steatosis a premalignant condition? Cancer Res (2001) 61(13):5016-5023.
38. Rose DP, Gilhooly EM, Nixon DW: Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin. Int J Oncol (2002) 21(6):1285-1292.
39. Hino M, Nakao T, Yamane T, Ohta K, Takubo T, Tatsumi N: Leptin receptor and leukemia. Leuk Lymphoma (2000) 36(5-6):457-461.
40. Hursting SD, Perkins SN, Donehower LA, Davis BJ: Cancer prevention studies in p53-deficient mice. Toxicol Pathol (2001) 29(1):137-141.
41. Kuchroo VK, Nicholson LB: Immunology: Fast and feel good? Nature (2003) 422(6927):27-28.
42. Steinman L, Conlon P, Maki R, Foster A: The intricate interplay among body weight, stress, and the immune response to friend or foe. J Clin Invest (2003) 111(2):183-185.